Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$143.0KMiss by $4.2M
EPS-$1.38Miss by $0.11
Revenue estimate$4.3M
EPS estimate-$1.27

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$14.8M
EPS estimate-$1.23

Financials

Q3 2025

Income statement

See full
Revenue$143.0K—
Operating income-$142.6M-62.4%
Net income-$130.1M-69.3%
EPS (diluted)-$1.38-43.7%

Balance sheet

See full
Cash & equivalents$112.2M-64.8%
Total debt$49.1M-6.5%
Total equity$1.1B+28.7%
Total assets$1.2B+27.6%

Cash flow

See full
Operating cash flow-$110.7M-76.2%
CapEx$863.0K+63.4%
Free cash flow-$111.6M-76.1%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.92B-4.1%
Enterprise value$3.86B+0.9%
P/S2,555.3×-1,381×

Profitability

See full
Operating margin-31,130.2%+1,789pp
Net margin-27,563.3%+867pp
FCF margin-23,337.1%+4,659pp

Returns & leverage

See full
Return on equity-44.4%+5.1pp
Debt / equity0×0.0×
Current ratio15.1×-1.3×

Segments

By segment

See full
Reportable Segment$143.0K—

Versus estimates

Revenue

Q1 2026$10.7MBeat by $2.2MQ4 2025$6.2MBeat by $1.7M
Q3 2025$143.0KMiss by $4.2M
Q2 2025$1.0MBeat by $637.0KQ1 2025$361.0KBeat by $13.1K

Diluted EPS

Q1 2026-$1.23Miss by $0.01Q4 2025-$1.29Beat by $0.08
Q3 2025-$1.38Miss by $0.11
Q2 2025-$1.23Miss by $0.10Q1 2025-$1.04Miss by $0.05Q4 2024-$0.88Beat by $0.04

Ask the moment Crinetics Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Crinetics Pharmaceuticals report Q3 2025 earnings?
Crinetics Pharmaceuticals (CRNX) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Crinetics Pharmaceuticals's Q3 2025 revenue and EPS?
Crinetics Pharmaceuticals reported revenue of $143.0K and eps of $-1.38 for Q3 2025.
Did Crinetics Pharmaceuticals beat estimates in Q3 2025?
Revenue missed the consensus estimate of $4.3M by $4.2M. EPS missed the consensus estimate of $-1.27 by $0.11.
How did Crinetics Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 43.7% from $-0.96.
Where can I find Crinetics Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001658247-25-000018) and the 10-Q periodic report (0001658247-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.